Warren Is Right. Presidents Have The Power To Bypass Congress On Drug Pricing.
But like all of health care, it’s complicated.
Drugs
661 - 680 of 1,299 Results
-
-
5 Things To Know About Trump’s Medicaid Block Grant Plan
Federal officials unveiled guidance for states that want to opt out of some of the current funding program and instead seek a fixed payment to gain more flexibility.
By Rachana Pradhan and Phil Galewitz -
A Guide To Following The Health Debate In The 2020 Elections
As the Democratic primary campaign nears pivotal voting, important aspects of health care policy are being overlooked.
By Julie Rovner -
Trump’s Latest Health Care Challenge: Gaining Voters’ Trust
The president, who has repeatedly pledged to improve health care and lower prescription drug prices, faces disapproval from a majority of Americans on his policies regarding drug costs, protecting people with preexisting conditions and the Affordable Care Act.
-
Call For FDA To Withdraw Preterm Birth Drug Divides Doctors and Insurers
A study ordered by the Food and Drug Administration failed to prove that Makena, the only drug approved to prevent premature birth, is effective. While a panel of experts has recommended withdrawing the drug’s approval, many doctors are wary.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
For 2020, California Goes Big On Health Care
California lawmakers are proposing ambitious health care ideas, from creating a state generic drug label to banning the sale of flavored e-cigarette products. Even though Democrats control state government, they’re likely to face pushback from powerful health care industry groups like hospitals.Â
-
Warren and Klobuchar Say They Can Lower Drug Prices Without Congress’ Help
Democratic presidential candidates also returned to now-familiar themes in debating the differences between "Medicare for All" and more incremental reforms.
-
Sanders Targets Health Industry Profits. Are His Figures Right?
Calculations are complicated, but correct.
-
Team Trump Says Administration’s Action On Health Care ‘Is Working.’ Is It?
The impact of the Trump administration’s health policies is not as clear-cut as the president’s reelection campaign suggests.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Family Doctors In Rural America Tackle Crisis Of Addiction And Pain
For rural physicians, the burden of responding to the opioid epidemic falls squarely on their already loaded shoulders. For one doctor in a small Wisconsin village, there was no question that she wanted to rise to the challenge.
-
Effort To Control Opioids In An ER Leaves Some Sickle Cell Patients In Pain
People with sickle cell disease aren't fueling the opioid crisis, research shows. Yet some ER doctors still treat patients seeking relief for agonizing sickle cell crises as potential addicts.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
-
Readers And Tweeters: More Than Two Sides To Every Story
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
-
Warren’s Argument That Millions Can’t Afford Their Rx Drugs Holds Up
‘Medication insecurity’ is a thing.
-
KHN’s ‘What The Health?’: ACA Still Under A Cloud After Court Ruling
A federal appeals court in New Orleans has agreed with a lower court that a key piece of the Affordable Care Act is unconstitutional. But it is sending the case back to the lower-court judge to decide how much of the rest of the law can stand. Also, Congress is leaving town after finishing work on a major spending bill that includes many changes to health policy. Margot Sanger-Katz of The New York Times, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
-
Border Fight: Trump’s Plan To Import Cheaper Drugs From Canada Faces Hurdles
The administration’s proposed rule to allow states to bring in prescription medications isn’t expected to provide immediate relief.
-
Listen: The Cost Of PrEP, The HIV Prevention Pill
KHN correspondent Shefali Luthra was among the guests on the podcast "Today, Explained" to talk about PrEP.